AlloVir Stock (NASDAQ: ALVR) stock price, news, charts, stock research, profile.
Open | $0.79 |
Close | $0.79 |
Volume / Avg. | 211.73K / 411.94K |
Day Range | 0.76 - 0.81 |
52 Wk Range | 0.58 - 3.79 |
Market Cap | $90.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 9.77% |
Days to Cover | 6.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AlloVir (NASDAQ:ALVR) through any online brokerage.
Other companies in AlloVir’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and FibroGen (NASDAQ:FGEN).
There is no analysis for AlloVir.
AlloVir has a consensus price target of $39.19.
The stock price for AlloVir (NASDAQ: ALVR) is $0.79 last updated July 15, 2024 at 4:00 PM EDT.
There are no upcoming dividends for AlloVir.
AlloVir’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for AlloVir.
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.